Wednesday, June 13, 2012

News and Notes for Wednesday June 13, 2012

Obama’s biobased purchase plan sees personal care products eligible for Federal procurement Obama’s plan to increase the purchase of biobased products to create jobs and drive innovation has led to a list of products, including skin care, being suggested for preferred Federal procurement. Read more.

Laying down the law on nanotechnology
The Guardian--Regulating nanotechnology is fraught with difficulties. Current environmental law simply doesn't apply on the nano-scale. Read more.

The Rigorous Road to Food Ingredient Approval additives are  evaluated, tightly regulated and regularly monitored by the Food and Drug Administration (FDA). The demanding approval process requires a manufacturer to petition the FDA, providing extensive evidence that the additive for which it is seeking approval is safe for its intended use. Read more.

Fish Oil Takes Down Lipids in Diabetics
MedPage Today--Diabetics with mixed dyslipidemia who were on statins and treated with the novel omega-3 fatty acid drug that is 96% pure eicosapentaenoic acid (EPA) improved their lipid profiles, without worsening glycemic control. Read more.

Omega XL Announces New Study: High Sugar Diet Sabotages Memory, Omega-3's Can Offset Damage
 MarketWatch (news release)--A new study published in the Journal of Physiology suggests a high fructose diet causes a decline in synaptic activity hampering learning and memory. Omega-3 essential fatty acid DHA, such as found in Omega XL, promotes brain health and can offset sugar's damaging effects.  Read the release.

Fatty Acids in Brain May Help Multiple Sclerosis Patients
BusinessWeek--Researchers showed that injecting high doses of the fatty acids, or lipids, into paralyzed mice with MS symptoms reduced inflammation in their brains and allowed them to regain movement within 24 to 36 hours. Read more. 

Have a news tip? Tip your editors at

No comments:

Post a Comment